FDA & Peptide Regulation
Explore peptide research and guides on fda & peptide regulation.
FDA & Peptide Regulation
The Lawsuit That Forced FDA to Rethink Its Peptide Ban
How Evexias and FarmaKeio's 2024 lawsuit challenged FDA's peptide restrictions under the Administrative Procedure Act, forcing a settlement and PCAC review.
FDA Peptide RegulationThymosin Alpha-1: How It Returned to Category 1
Thymosin alpha-1 was moved from FDA Category 2 back to Category 1 in 2026, restoring compounding pharmacy access. Here is the timeline and evidence behind it.
FDA Peptide RegulationPeptide Reclassification Is Not FDA Approval
FDA reclassification lets compounding pharmacies prepare peptides again. It does not mean those peptides are FDA-approved, tested, or proven safe and effective.